In the deal, the St. Paul, MN-based company will acquire M*Modal’s technology business in a deal valued at $1 billion.
ReShape Medical will sell its intra-gastric balloon and acquire the Lap-Band in a deal worth about $17 million that has implications for the obesity treatment landscape.
Boston Scientific is Editor’s Choice for 2018 Company of the Year because of its numerous acquisitions, meticulous planning, and its unwillingness to stay silent when tackling controversy. The Marlborough, MA-based company is on the cusp of change.
Sonic Healthcare revealed it has entered into an agreement to acquire Aurora Diagnostics for $540 million.
The Danvers, MA-based company is poised to invest $15 million in Shockwave Medical and work on a training and education program with the intravascular lithotripsy specialist.
Check-Cap received CE mark for its C-Scan Capsule in January of this year, now the Isfiya, Israel-based company is setting its sights on the U.S. market.
Pear Therapeutics has received a nod from FDA to market reSET-O, an app used to help those with opioid use disorder stay in recovery programs.
Osaka University researchers have developed an AI-based system that has the potential to differentiate between different types of cancer cells. The research could have major implications in the field of oncology.
The Galway, Ireland-based company has raised $30 million to help develop its approach to drain the excess fluid found in acute decompensated heart failure patients.
The company also released a weak outlook for 2019 and saw shares drop a little more than 17% as a result.
The partnership between Edwards Lifesciences and Bay Labs continues the trend of larger medtech firms teaming up with companies in the artificial intelligence space to enhance existing devices.
The medtech space was definitely piping hot with M&A activity earlier this year, but do firms still have that same thirst for deals going into 2019?
The Marlborough, MA-based company said it could pick up a CE mark for the endoscopic ablation system sometime in mid-2019.